Kivel Richard 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Jun 8, 2011
Insider Transaction Report
Form 4
Kivel Richard
Director
Transactions
- Award
Stock Options (right-to-buy)
2011-06-06+20,000→ 20,000 totalExercise: $1.25Exp: 2021-06-06→ Common Stock (20,000 underlying)
Holdings
- 20,000
Stock Options (right-to-buy)
Exercise: $1.19Exp: 2010-09-17→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]These options vest and become exercisable in full on June 6, 2012.
- [F2]These options vest and become exercisable in full on September 17, 2011.